CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.200
-0.010 (-0.45%)
Apr 29, 2025, 4:00 PM EDT - Market closed
CollPlant Biotechnologies Stock Forecast
CLGN's stock price has decreased by -62.65% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CollPlant Biotechnologies stock have an average target of 12.5, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 468.18% from the current stock price of 2.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 27, 2025.
Analyst Ratings
The average analyst rating for CollPlant Biotechnologies stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +536.36% | Mar 27, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +536.36% | Feb 12, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +536.36% | Feb 4, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +400.00% | Nov 29, 2024 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +536.36% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
11.73M
from 515.00K
Increased by 2,177.67%
Revenue Next Year
18.36M
from 11.73M
Increased by 56.52%
EPS This Year
-0.11
from -1.45
EPS Next Year
0.03
from -0.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 12.1M | 18.9M | 8.9M |
Avg | 11.7M | 18.4M | 8.7M |
Low | 11.3M | 17.6M | 8.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2,244.7% | 61.1% | -51.4% |
Avg | 2,177.7% | 56.5% | -52.8% |
Low | 2,088.3% | 50.4% | -54.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.12 | 0.03 | -0.23 |
Avg | -0.11 | 0.03 | -0.22 |
Low | -0.11 | 0.03 | -0.22 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.